Net shares · 365d
-23.9K
0 buy · 23.9K sell
Net value · 365d
-$4.5M
$0 in · $4.5M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
9
0 buy · 23.9K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
DGX Other·L
SVP for Diagnostic Services
$9.5K
49 sh · $194.70
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$588.7K
2.9K sh · $206.21
Own -16%
-
DGX Grant·A
SVP for Diagnostic Services · 10b5-1
$1.2M
5.7K sh · $204.86
Own +37%
-
DGX Other·F
SVP for Diagnostic Services · 10b5-1
$579.1K
2.8K sh · $204.86
Own -14%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$85.2K
410 sh · $207.73
Own -3%
-
DGX Other·F
SVP for Diagnostic Services · 10b5-1
$47.1K
230 sh · $204.86
Own -1%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$196.2K
958 sh · $204.83
Own -6%
-
DGX Grant·A
SVP for Diagnostic Services · 10b5-1
$0
9.0K sh
Own New
-
DGX Grant·A
SVP for Diagnostic Services · 10b5-1
$0
2.0K sh
Own +13%
-
DGX Other·F
SVP for Diagnostic Services · 10b5-1
$111.9K
537 sh · $208.36 avg · 2 lots
Own -3%
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$689.7K
5.7K sh · $121.81
Own New
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$689.7K
5.7K sh · $121.81
Own +37%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$1.2M
5.7K sh · $204.00
Own -27%
-
DGX Grant·A
SVP for Diagnostic Services · 10b5-1
$8.8K
48 sh · $183.51
Own +0%
-
DGX Grant·A
SVP for Diagnostic Services
$8.7K
46 sh · $189.08
Own +0%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$365.4K
2.0K sh · $185.00
Own -11%
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$508.4K
4.5K sh · $112.17
Own New
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$829.4K
4.5K sh · $183.00
Own -21%
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$508.4K
4.5K sh · $112.17
Own +26%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$355.5K
2.0K sh · $180.00
Own -10%
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$308.4K
3.6K sh · $86.63
Own New
-
DGX Exercise·M
SVP for Diagnostic Services · 10b5-1
$308.4K
3.6K sh · $86.63
Own +17%
-
DGX Sell·S
SVP for Diagnostic Services · 10b5-1
$968.6K
5.5K sh · $175.00 avg · 2 lots
Own -21%
-
DGX Other·L
SVP for Diagnostic Services
$13.4K
80 sh · $167.49
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Apr 20, 2026 | DGX | Other L | 49 | $9.5K |
| Mar 5, 2026 | DGX | Sell S | 2.9K | $588.7K |
| Mar 4, 2026 | DGX | Grant A | 5.7K | $1.2M |
| Mar 4, 2026 | DGX | Other F | 2.8K | $579.1K |
| Mar 3, 2026 | DGX | Sell S | 410 | $85.2K |
| Mar 2, 2026 | DGX | Other F | 230 | $47.1K |
| Feb 19, 2026 | DGX | Sell S | 958 | $196.2K |
| Feb 18, 2026 | DGX | Grant A | 9.0K | $0 |
| Feb 18, 2026 | DGX | Grant A | 2.0K | $0 |
| Feb 18, 2026 | DGX | Other F | 5372 lots | $111.9K |
| Feb 10, 2026 | DGX | Exercise M | 5.7K | $689.7K |
| Feb 10, 2026 | DGX | Exercise M | 5.7K | $689.7K |
| Feb 10, 2026 | DGX | Sell S | 5.7K | $1.2M |
| Jan 28, 2026 | DGX | Grant A | 48 | $8.8K |
| Oct 21, 2025 | DGX | Grant A | 46 | $8.7K |
| Aug 21, 2025 | DGX | Sell S | 2.0K | $365.4K |
| Aug 19, 2025 | DGX | Exercise M | 4.5K | $508.4K |
| Aug 19, 2025 | DGX | Sell S | 4.5K | $829.4K |
| Aug 19, 2025 | DGX | Exercise M | 4.5K | $508.4K |
| Aug 15, 2025 | DGX | Sell S | 2.0K | $355.5K |
| Aug 6, 2025 | DGX | Exercise M | 3.6K | $308.4K |
| Aug 6, 2025 | DGX | Exercise M | 3.6K | $308.4K |
| Aug 6, 2025 | DGX | Sell S | 5.5K2 lots | $968.6K |
| Jul 21, 2025 | DGX | Other L | 80 | $13.4K |
Buy Sell Non-market (grant · exercise · gift)
About Plewman Patrick
This profile aggregates every SEC Form 4 insider transaction reported by Plewman Patrick across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.